Skip to content

Transcutaneous Electric Nerve Stimulation as a therapeutic management of Temporomandibular joint disorder pain.

Assessment of the effectiveness of Transcutaneous Electric Nerve Stimulation (TENS) and Diclofenac in the management of Temporomandibular joint disorder (TMD) pain - a single - blind randomized controlled trial.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041525
Enrollment
28
Registered
2022-03-31
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K088- Other specified disorders of teethand supporting structures

Interventions

Intervention1: Transcutaneous Electric Nerve Stimulation (TENS): Patients with Temporomandibular joint disorder (TMD) pain requiring Transcutaneous Electric Nerve Stimulation (TENS). Patients will be
Pulse width 100 and Mode will be continuous. Control Intervention1: Diclofenac sodium: Patients with Temporomandibular joint disorder (TMD) pain requiring systemic pharmacotherapy. Diclofenac sodium 5

Sponsors

Saveetha Dental College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with pain associated with Temporomandibular joint 2. Patients clinically and/or radiographically diagnosed as Temporomandibular joint disorder 3. Patients with or without TMJ associated muscle(s) pain 4. Ability to understand the Chronic Pain Grading Scale (CPGS) criteria 5. Ability to respond to Chronic Pain Grading Scale (CPGS) questions 5. Patients of all age group and gender included

Exclusion criteria

Exclusion criteria: 1. Patients with cardiac pacemakers, epilepsy, dermatological diseases in face and pregnancy 2. Patients with chief complaint other than TMD pain 3. Patients with RTA, fracture and pain arising from it 4. Patients with pathology like cysts, tumour involving TMJ 5. Inability to understand and respond to the Chronic Pain Grading Scale (CPGS) criteria 6. TMD patients requiring surgical management

Design outcomes

Primary

MeasureTime frame
Reduction in pain intensityTimepoint: Four weeks

Secondary

MeasureTime frame
Improvement in mouth openingTimepoint: Four weeks;Reduction or absence of clicking noiseTimepoint: Four weeks

Countries

India

Contacts

Public ContactDr Indra G

Saveetha Dental College and Hospital

drgopalvalli@gmail.com9445171146

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026